Melbourne, Australia · Founded 2020 · Privately Held (backing)
Developer of CAR-T cell therapies designed to treat solid cancers. Currus Biologics is based in Melbourne, Australia and was founded in 2020. Its last reported valuation was $21.6 million in Oct 2025. It has raised $19.3 million.
Last reported valuation
$21.6M
Oct 2026
Priced at
—
Total raised
$19.3M
Last round
—
Team — not yet on record
No current team members for Currus Biologics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Currus Biologics with a free account
·Watch Currus Biologics: the Monday email on marks, rounds and moves
